About the Blending Initiative:

Accelerating the dissemination of research-based drug abuse treatment into clinical practice is a priority for the National Institute on Drug Abuse (NIDA) and represents the core mission of the Blending Initiative. NIDA and the Substance Abuse and Mental Health Services Administration (SAMHSA) joined together to create the Blending Initiative in 2001 to reduce the gap that exists between the publication of research results and impact on treatment delivery. This initiative incorporates collaboration between clinicians, scientists, and experienced trainers to catalyze the creation of user-friendly treatment tools and products and facilitate the adoption of research-based interventions into front-line clinical settings. Through this initiative, NIDA and SAMHSA’s Addiction Technology Transfer Centers (ATTCs) disseminate treatment and training products based on results from studies conducted by the National Drug Abuse Clinical Trials Network (CTN) as well as other NIDA-supported research.  For additional information on the Blending Initiative, contact:

Joanna Weston, MPH
Email: JWeston@leedmci.com

The Blending Initiative comprises three components:

Blending Products and Materials;
Blending Meetings and Conferences; and
Collaborative Partnerships
Through these components, and together with SAMHSA, NIDA facilitates the adoption of research-based interventions into front-line clinical settings.

Products & Materials:

NIDA Blending Products and Materials constitute a primary mode of research translation toward clinical practice in the drug abuse field. Blending Teams, consisting of NIDA researchers, treatment practitioners, trainers from SAMHSA’s ATTC Network, NIDA staff, and subject matter and communications experts, work closely together to develop training curricula, manuals, tools, and other resource materials based on NIDA-supported research. Blending Products introduced into the field have covered such topics as Motivational Interviewing, HIV Rapid Testing, Motivational Incentives/Contingency Management, and Buprenorphine Treatment for Opioid Use Disorders. Recent efforts have included an infographic on the role of Smoking Cessation in Addiction Treatment, along with web-based simulation training for Motivational Interviewing. 

Covers of Buprenorphine and HIV Testing products

Buprenorphine Treatment: Training for Multidisciplinary Addiction Professionals (2005)

Short-Term Opioid Withdrawal Using Buprenorphine: Findings and Strategies from a NIDA Clinical Trials Network (CTN) Study (2006)

Buprenorphine Treatment for Young Adults (2010)

The Prescription Opioid Addiction Treatment Study (POATS): Treatment Strategies for Prescription Opioid Dependence and Information (2012)

Promoting Awareness of Motivational Incentives (PAMI) (Revised 2011)

Motivational Incentives: Positive Reinforcers to Enhance Successful Treatment Outcomes (MI:PRESTO) (2011)

Motivational Incentives Implementation Software (MIIS) (2011)



Hosted at A2